Medical studies (Saarland University: 1985-1992/1993), research year in cell biology as a scholarship holder at the University of Massachussetts/ USA. Medical internship 1992, license to practice medicine 1994
Promotion 1994 (Dr. med.)
Specialist training in internal medicine (RWTH Aachen 1993-96 and Charité Berlin 1996-2003)
KAP research year at the Max Delbrück Center Berlin Buch
2000 Specialist in internal medicine, additional qualifications in cardiology, diabetology, sports medicine, internal intensive care medicine. Preventive medicine specialist DAPM. Certificate in health promotion and prevention (ÄK Nordrhein) Emergency physician.
S Gerbaulet1, M Sigmund, S Hauptmann, U Janssens, Quantification of cell proliferation with the proliferation marker MIB-1 in endomyocardial biopsies after heart transplantation. An aid in diagnosis of graft rejection needing treatment? Link
Gerbaulet SP, van Wijnen AJ, Aronin N, Tassinari MS, Lian JB, Stein JL, Stein GS. J Cell Biochem. 1992 Jun;49(2):137-47. Downregulation of histone H4 gene transcription during postnatal development in transgenic mice and at the onset of differentiation in transgenically derived calvarial osteoblast cultures Link
J Bohlender1, S Gerbaulet, J Krämer, M Gross, M Kirchengast, R Dietz. Synergistic effects of AT(1) and ET(A) receptor blockade in a transgenic, angiotensin II-dependent, rat model Link
Gerbaulet SP, Krämer J, Bohlender J, Dietz R, Gross CM. Kidney Blood Press Res. 2005;28(3):134-43. Blood pressure-independent ETA and AT1 receptor blocker effects on the coronaries of rats harboring human renin and angiotensinogen genes. Link
Gross CM, Gerbaulet S, Quensel C, Krämer J, Mittelmeier HO, Luft FC, Dietz R. Basic Res Cardiol. 2002 Jul;97(4):327-33. Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis. Link